Literature DB >> 1399111

Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis.

S Zucker1, R M Lysik, M Malik, B A Bauer, J Caamano, A J Klein-Szanto.   

Abstract

Numerous studies have reported a correlation between production of 72-kDa (MMP-2) and 92-kDa (MMP-9) type-IV collagenases/gelatinases and the metastatic potential of cancer cells. An abrogating effect of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) on metastases has also been noted. In this report we have used sensitive enzyme-linked immunoassays to measure MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in eight human lung-cancer cell lines which were characterized for biological behavior in nude mice. We demonstrated that the Calu-6 and A549 cell lines with the highest metastatic, invasive and tumorigenic potential secreted the highest levels of MMP-2. MMP-9 and TIMP-1 secretions were comparatively low in all cell lines. TIMP-2 secretion, which exceeded MMP-2 secretion for all cell lines, did not correlate with metastatic potential. To further explore these correlations, the metastatic Calu-6 cell line was transfected with a K-rev-1 cDNA expression construct. The K-rev revertant cell lines demonstrated a more differentiated phenotype and were less tumorigenic, invasive and metastatic in nude mice. Nonetheless, the Calu-6 revertant cell lines secreted higher levels of MMP-2 than the parent cell line. In conclusion, invasion and metastasis by lung-cancer cells requires not only enhanced MMP production, but also other less well-understood tumorigenic characteristics. The multiplicity of factors required by cancer cells for dissemination helps to explain the minute fraction of cancer cells from a primary tumor that ever develop into a metastasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1399111     DOI: 10.1002/ijc.2910520307

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.

Authors:  T Hayashi; W G Stetler-Stevenson; M V Fleming; N Fishback; M N Koss; L A Liotta; V J Ferrans; W D Travis
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

2.  Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.

Authors:  M Shindoh; F Higashino; M Kaya; M Yasuda; K Funaoka; M Hanzawa; K Hida; T Kohgo; A Amemiya; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  Type IV collagenase in squamous cell and basal cell skin carcinomas.

Authors:  N Slade; J Pavelić; B Kurslin; K Pavelić
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 4.  Systemic inflammatory changes and their clinical implications following thoracic cancer surgery.

Authors:  Massimiliano Fornasiero; Georgios Geropoulos; Dimitrios Giannis; Joshua Enson; Julian Aquilina; Niraj Kumar; Kunal Bhakhri; Nikolaos Panagiotopoulos
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-23

5.  Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells.

Authors:  Hiromichi Nakabayashi; Toshio Yawata; Keiji Shimizu
Journal:  BMC Cancer       Date:  2010-06-29       Impact factor: 4.430

6.  Immunohistopathological characterizatin of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) xenograft.

Authors:  M V Croce; A G Colussi; M G De Bravo; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

7.  Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.

Authors:  S Zucker; P Mancuso; B DiMassimo; R M Lysik; C Conner; C L Wu
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

8.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.

Authors:  D A Arenberg; S L Kunkel; P J Polverini; S B Morris; M D Burdick; M C Glass; D T Taub; M D Iannettoni; R I Whyte; R M Strieter
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

Review 9.  Molecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic Implications.

Authors:  Gabriela Vilema-Enríquez; Aurora Arroyo; Marcelo Grijalva; Ricardo Israel Amador-Zafra; Javier Camacho
Journal:  Oxid Med Cell Longev       Date:  2016-06-08       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.